Page 54 - Demo

P. 54


                                
                                    Phase 2 Trial of Disitamab Vedotin + Pembrolizumab in Treatment-Na%u00efve HER2-Expressing aUC: Cohort CGalsky MD, et al. ESMO 2024. Abstract 1967MO.

48 49 50 51 52 53 54 55 56 57 58